Efficient chemotherapy of rat glioblastoma using doxorubicin-loaded PLGA nanoparticles with different stabilizers.
Standard
Efficient chemotherapy of rat glioblastoma using doxorubicin-loaded PLGA nanoparticles with different stabilizers. / Wohlfart, Stefanie; Khalansky, Alexander S; Gelperina, Svetlana; Maksimenko, Olga; Bernreuther, Christian; Glatzel, Markus; Kreuter, Jörg.
in: PLOS ONE, Jahrgang 6, Nr. 5, 5, 2011, S. 19121.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Efficient chemotherapy of rat glioblastoma using doxorubicin-loaded PLGA nanoparticles with different stabilizers.
AU - Wohlfart, Stefanie
AU - Khalansky, Alexander S
AU - Gelperina, Svetlana
AU - Maksimenko, Olga
AU - Bernreuther, Christian
AU - Glatzel, Markus
AU - Kreuter, Jörg
PY - 2011
Y1 - 2011
N2 - Chemotherapy of glioblastoma is largely ineffective as the blood-brain barrier (BBB) prevents entry of most anticancer agents into the brain. For an efficient treatment of glioblastomas it is necessary to deliver anti-cancer drugs across the intact BBB. Poly(lactic-co-glycolic acid) (PLGA) nanoparticles coated with poloxamer 188 hold great promise as drug carriers for brain delivery after their intravenous injection. In the present study the anti-tumour efficacy of the surfactant-coated doxorubicin-loaded PLGA nanoparticles against rat glioblastoma 101/8 was investigated using histological and immunohistochemical methods.
AB - Chemotherapy of glioblastoma is largely ineffective as the blood-brain barrier (BBB) prevents entry of most anticancer agents into the brain. For an efficient treatment of glioblastomas it is necessary to deliver anti-cancer drugs across the intact BBB. Poly(lactic-co-glycolic acid) (PLGA) nanoparticles coated with poloxamer 188 hold great promise as drug carriers for brain delivery after their intravenous injection. In the present study the anti-tumour efficacy of the surfactant-coated doxorubicin-loaded PLGA nanoparticles against rat glioblastoma 101/8 was investigated using histological and immunohistochemical methods.
KW - Animals
KW - Humans
KW - Male
KW - Rats
KW - Rats, Wistar
KW - Lactic Acid/chemistry
KW - Polyglycolic Acid/chemistry
KW - Calorimetry, Differential Scanning
KW - Doxorubicin/administration & dosage/chemistry/therapeutic use
KW - Glial Fibrillary Acidic Protein/metabolism
KW - Glioblastoma/drug therapy/metabolism
KW - Nanoparticles/administration & dosage/chemistry
KW - Vascular Endothelial Growth Factor A/metabolism
KW - Animals
KW - Humans
KW - Male
KW - Rats
KW - Rats, Wistar
KW - Lactic Acid/chemistry
KW - Polyglycolic Acid/chemistry
KW - Calorimetry, Differential Scanning
KW - Doxorubicin/administration & dosage/chemistry/therapeutic use
KW - Glial Fibrillary Acidic Protein/metabolism
KW - Glioblastoma/drug therapy/metabolism
KW - Nanoparticles/administration & dosage/chemistry
KW - Vascular Endothelial Growth Factor A/metabolism
U2 - 10.1371/journal.pone.0019121
DO - 10.1371/journal.pone.0019121
M3 - SCORING: Journal article
VL - 6
SP - 19121
JO - PLOS ONE
JF - PLOS ONE
SN - 1932-6203
IS - 5
M1 - 5
ER -